NASDAQ:CRSP   CRISPR Therapeutics AG
From 2018 to 2020, there may just be an alphabet and a different line, but it is not applied by ALT variants.
You can tarnish after the test with blue.
It can go lower, since the 5th stretched was-the zones are on the chart.

All development is in the distant future, the stock is VERY volatile, it can easily still go to the prices of the 90-70 level. It is more suitable for medium-and long-term investors. This is a deal up to 3 is possible only under extremely favorable circumstances, so it is from a year.
Entry point # 1-High risk:
According to the current ones, we are catching a U-turn. "catching a knife".
Entry point # 2-Conservative strategy (safe):
$ 128.4. This is a level above all emas. We are waiting for a breakdown, a rollback and again growth from this level – this is the safest option, since the price can go to the 90-70 zone. We will consider further the scenario when the price is fixed above our level.
P/R=3,5
✅ Take profit:
TP1= $ 144.37 (30% fixed – serious resistance)
TP2= $ 160 (65% fixed-serious resistance)
TP2. 5= $ 182 (75% fixed-intermediate, where you can close the entire transaction, those who believe in the future of CRISP technology can leave. P/R=5.5.)
T3-T4 – Long-range goals to where the price will go, in case of success with the company. TP3-resistance – here already P/R=9.3
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.